AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Policy Tracker · Official source

Japan

Where this status comes from, in the government's own words.

Current status

Prohibited

Illegal to possess, use or sell.

Not yet checked against the official law — treat as provisional.

Official law

Narcotics and Psychotropics Control Act [麻薬及び向精神薬取締法]

Published by mhlw.go.jp

Article 28(1) — Possession [所持]
第二十八条　麻薬取扱者、麻薬診療施設の開設者又は麻薬研究施設の設置者でなければ、麻薬を所持してはならない。ただし、次に掲げる場合は、この限りでない。

Show on the map Country overview All legal sources

Loading source…